Medicines Co (MDCO) Tops Q1 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Join SI Premium – FREE
Medicines Co (NASDAQ: MDCO) reported Q1 EPS of $0.27, $0.13 better than the analyst estimate of $0.14. Revenue for the quarter came in at $126.6 million versus the consensus estimate of $123.99 million.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises Keurig Dr Pepper price target to $40
- Lime Energy (LIME) Reports Q3 EPS of $0.63 ; Offers Guidance
- Seaboard Corp. (SEB) Tops Q3 EPS by 2923c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
